Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase IIa, Placebo-Controlled, Randomized Study of Daily Obeticholic Acid OCA to Reduce Intestinal Polyp Burden in Familial Adenomatous Polyposis FAP
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers in Women with Obesity and Other Risk Factors for Breast Cancer
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT06485089
Principal Investigator:
Carol Fabian
Phase 1b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Repeated Doses of DB-020 in Patients Receiving Cisplatin
A Multicenter Study of 5-Aminolevulinic Acid 5-ALA to Enhance Visualization of Malignant Tumor in Patients with Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation
Study Type: Prevention
Phase: III
NCTID: NCT05711667
Principal Investigator:
Ibrahim Ahmed
A Phase IB, Open-Label, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of UTTR1147A in Combination with Standard of Care in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations
Study Type: Prevention
Phase: N/A
NCTID: NCT03100461
Principal Investigator:
Keith Allen Greiner JR
Testing for Atypia in Random Periareolar Fine Needle Aspiration RPFNA Cytology after 12 Months Metformin 1, 1-Dimethylbiguanide Hydrochloride Chemoprevention versus Placebo Control in Premenopausal Women
Pilot Study of Effects of Bazedoxifene plus Conjugated Estrogen on Imaging and Blood Biomarkers In Women with Menopausal Symptoms at Increased Risk for Breast Cancer
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT04821375
Principal Investigator:
Carol Fabian
The Effectiveness of Lactobacillus Plantarum LBP in Preventing Acute Graft-Versus-Host Disease GvHD in Children Undergoing Alternative Hematopoietic Progenitor Cell Transplantation HCT
Study Type: Prevention
Phase: III
NCTID: NCT03057054
Principal Investigator:
Keith August